Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy

Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy

Abstract Chimeric antigen receptor (CAR) engineered cellular immunotherapy offers the potential for precise targeting and elimination of tumor cells, providing a tailored approach to cancer treatment. CAR-T cells demonstrate significant anti-tumor activity among these therapies. Nonetheless, these t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yong Liu, Yifei Duan, Zefan Du, Bo Lu, Su Liu, Lindi Li, Mengyao Tian, Liang Li, Ran Yao, Cheng Ouyang, Mo Yang, Chun Chen
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Experimental Hematology & Oncology
Subjects:
CAR-T
CAR-NK
CAR-M
Immunotherapy
Clinical application
Online Access:https://doi.org/10.1186/s40164-025-00683-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40164-025-00683-y

Similar Items